Gaitan E, Lindsay R H, Reichert R D, Ingbar S H, Cooksey R C, Legan J, Meydrech E F, Hill J, Kubota K
University of Mississippi Medical School, Jackson.
J Clin Endocrinol Metab. 1989 Apr;68(4):707-14. doi: 10.1210/jcem-68-4-707.
Pearl millet [Pennisetum millet (L.) leeke] is the main source of food energy for the rural poor in many areas of the semiarid tropics. Epidemiological evidence suggests that millet may play a role in the genesis of endemic goiter in these areas, and sparse experimental data in rats support this suspicion. This study was undertaken to determine in vivo in rats and in vitro using porcine thyroid slices and a thyroid peroxidase (TPO) assay the goitrogenic and antithyroid effects of millet diets, extracts of millet, and certain pure compounds contained therein. For use in these studies, whole grain millet was progressively dehulled to yield successively four bran and four flour fractions in which direct analyses revealed progressively lower concentrations of C-glycosylflavones. In vivo feeding of bran fraction 1, that richest in C-glycosylflavones, led to a significant increase in thyroid weight and antithyroid effects. Feeding of bran fraction 2, the next richest in C-glycosylflavones, produced similar, but less marked, changes. In vitro studies of 125I metabolism using porcine thyroid slices indicated that extracts of bran fractions 1 and 2 were most potent, producing changes similar to those produced by methimazole (MMI). At a concentration of 60 mumol/L, glucosylvitexin, the major C-glycosylflavone present in millet, had effects comparable to those of 1 mumol/L MMI. Similarly, in studies of porcine TPO, extracts of bran fraction 1 caused pronounced (85%) inhibition of enzyme activity, and progressively less inhibition was induced by extracts of bran fractions 2, 3, and 4. Overall, the TPO-inhibiting activities of the various millet fractions closely correlated with their C-glycosylflavone concentrations. Three C-glycosylflavones present concentrations. Three C-glycosylflavones present in millet, glucosylvitexin, glycosylorientin, and vitexin, also inhibited TPO activity. Thus, in vivo and in vitro studies revealed that millet diets rich in C-glycosylflavones produce goitrogenic and antithyroid effects similar to those of certain other antithyroid agents and small doses of MMI. We conclude that in areas of iodine deficiency in which millet is a major component of the diet, its ingestion may contribute to the genesis of endemic goiter.
珍珠粟[狼尾草属粟(L.)利克]是半干旱热带许多地区农村贫困人口食物能量的主要来源。流行病学证据表明,粟可能在这些地区地方性甲状腺肿的发生中起作用,而大鼠的少量实验数据支持了这一怀疑。本研究旨在通过大鼠体内实验以及使用猪甲状腺切片和甲状腺过氧化物酶(TPO)测定法进行体外实验,来确定粟日粮、粟提取物以及其中所含某些纯化合物的致甲状腺肿和抗甲状腺作用。为用于这些研究,将全谷物粟逐步脱壳,依次得到四个麸皮部分和四个面粉部分,直接分析显示其中C - 糖基黄酮的浓度逐渐降低。给大鼠喂食C - 糖基黄酮含量最高的第1号麸皮部分,导致甲状腺重量显著增加和抗甲状腺作用。喂食C - 糖基黄酮含量次之的第2号麸皮部分,产生了类似但不太明显的变化。使用猪甲状腺切片对125I代谢进行的体外研究表明,第1号和第2号麸皮部分的提取物作用最强,产生的变化与甲巯咪唑(MMI)产生的变化相似。在浓度为60 μmol/L时,粟中存在的主要C - 糖基黄酮葡糖基牡荆素的作用与1 μmol/L MMI的作用相当。同样,在对猪TPO的研究中,第1号麸皮部分的提取物导致酶活性明显(85%)抑制,而第2号、第3号和第4号麸皮部分的提取物诱导的抑制作用逐渐减弱。总体而言,各种粟部分的TPO抑制活性与其C - 糖基黄酮浓度密切相关。粟中存在的三种C - 糖基黄酮,葡糖基牡荆素、糖基荭草素和牡荆素,也抑制TPO活性。因此,体内和体外研究表明,富含C - 糖基黄酮的粟日粮产生的致甲状腺肿和抗甲状腺作用与某些其他抗甲状腺药物和小剂量MMI的作用相似。我们得出结论,在碘缺乏地区,粟是饮食的主要组成部分,摄入粟可能有助于地方性甲状腺肿的发生。